SUTRO BIOPHARMA, INC. (STRO) Net income 2016–2025
SUTRO BIOPHARMA, INC. (STRO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$191.0MFY2025 · since FY2016: $1.7M → -$191.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$191.0M | +15.9% |
| FY2024 | -$227.0M | -112.1% |
| FY2023 | -$107.0M | +10.2% |
| FY2022 | -$119.2M | -12.9% |
| FY2021 | -$105.5M | -228.5% |
| FY2020 | -$32.1M | +73.0% |
| FY2019 | -$119.2M | -237.5% |
| FY2018 | -$35.3M | -79.4% |
| FY2017 | -$19.7M | -1256.8% |
| FY2016 | $1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice